WATSON 240 0.5 (Lorazepam 0.5 mg)

Pill with imprint WATSON 240 0.5 is White, Round and has been identified as Lorazepam 0.5 mg. It is supplied by Watson Laboratories, Inc.

Lorazepam is used in the treatment of anxiety; icu agitation; insomnia; light anesthesia; nausea/vomiting and belongs to the drug classes benzodiazepine anticonvulsants, benzodiazepines, miscellaneous antiemetics. There is positive evidence of human fetal risk during pregnancy. Lorazepam 0.5 mg is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).

Images for WATSON 240 0.5

Imprint: WATSON 240 0.5
Strength: 0.5 mg
Color: White
Size: 6.00 mm
Shape: Round
Availability: Prescription only
Drug Class: Benzodiazepine anticonvulsants, Benzodiazepines, Miscellaneous antiemetics
Pregnancy Category: D - Positive evidence of risk
CSA Schedule: 4 - Some potential for abuse
Labeler / Supplier: Watson Laboratories, Inc.
Inactive Ingredients: lactose, magnesium stearate, microcrystalline cellulose, polacrilin potassium
Note: Inactive ingredients may vary.

NDC Code	Labeler / Repackager
00591-0240	Watson Pharmaceuticals, Inc.
63739-0499 (Discontinued)	McKesson Packaging Services
66267-0133 (Discontinued)	Nucare Pharmaceuticals Inc. (repackager)
43063-0057	PDRX Pharmaceuticals Inc. (repackager)
55289-0402	PDRX Pharmaceuticals Inc. (repackager)